Bank of America’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-561
| Closed | -$392 | – | 8379 |
|
|
2023
Q4 | $392 | Hold |
561
| – | – | ﹤0.01% | 7307 |
|
|
2023
Q3 | $386 | Hold |
561
| – | – | ﹤0.01% | 7345 |
|
|
2023
Q2 | $1.35K | Buy |
561
+193
| +52% | +$824 | ﹤0.01% | 7200 |
|
|
2023
Q1 | $2.96K | Sell |
368
-201
| -35% | -$2.67K | ﹤0.01% | 7167 |
|
|
2022
Q4 | $6.73K | Buy |
569
+5
| +0.9% | +$57 | ﹤0.01% | 7005 |
|
|
2022
Q3 | $8K | Hold |
564
| – | – | ﹤0.01% | 7294 |
|
|
2022
Q2 | $20K | Sell |
564
-23
| -4% | -$718 | ﹤0.01% | 7191 |
|
|
2022
Q1 | $24K | Buy |
587
+93
| +19% | +$3.99K | ﹤0.01% | 7460 |
|
|
2021
Q4 | $21K | Buy |
494
+309
| +167% | +$19.3K | ﹤0.01% | 7508 |
|
|
2021
Q3 | $13K | Buy |
185
+27
| +17% | +$1.98K | ﹤0.01% | 7514 |
|
|
2021
Q2 | $12K | Buy |
158
+1
| +0.6% | +$61 | ﹤0.01% | 7267 |
|
|
2021
Q1 | $10K | Hold |
157
| – | – | ﹤0.01% | 7020 |
|
|
2020
Q4 | $5K | Hold |
157
| – | – | ﹤0.01% | 6833 |
|
|
2020
Q3 | $9K | Hold |
157
| – | – | ﹤0.01% | 6487 |
|
|
2020
Q2 | $6K | Hold |
157
| – | – | ﹤0.01% | 6545 |
|
|
2020
Q1 | $4K | Hold |
157
| – | – | ﹤0.01% | 6552 |
|
|
2019
Q4 | $8K | Hold |
157
| – | – | ﹤0.01% | 6694 |
|
|
2019
Q3 | $8K | Sell |
157
-19
| -11% | -$1.36K | ﹤0.01% | 6769 |
|
|
2019
Q2 | $16K | Sell |
176
-7
| -4% | -$851 | ﹤0.01% | 6628 |
|
|
2019
Q1 | $27K | Buy |
183
+26
| +17% | +$5.03K | ﹤0.01% | 6418 |
|
|
2018
Q4 | $25K | Hold |
157
| – | – | ﹤0.01% | 6434 |
|
|
2018
Q3 | $39K | Buy |
157
+85
| +118% | +$20.1K | ﹤0.01% | 6316 |
|
|
2018
Q2 | $16K | Buy |
72
+1
| +1% | +$268 | ﹤0.01% | 6572 |
|
|
2018
Q1 | $18K | Hold |
71
| – | – | ﹤0.01% | 6419 |
|
|
2017
Q4 | $22K | Hold |
71
| – | – | ﹤0.01% | 6389 |
|
|
2017
Q3 | $26K | Sell |
71
-4
| -5% | -$1.42K | ﹤0.01% | 6178 |
|
|
2017
Q2 | $27K | Buy |
+75
| New | +$22.5K | ﹤0.01% | 6126 |
|
|
2016
Q4 | – | Sell |
-3
| Closed | -$1K | – | 7400 |
|
|
2016
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 6992 |
|
|
2016
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 7026 |
|
|
2016
Q1 | $1K | Sell |
3
-2
| -40% | -$715 | ﹤0.01% | 6887 |
|
|
2015
Q4 | $2K | Buy |
+5
| New | +$1.57K | ﹤0.01% | 7121 |
|
|
2015
Q2 | – | Sell |
-29
| Closed | -$8K | – | 7464 |
|
|
2015
Q1 | $8K | Buy |
+29
| New | +$12.5K | ﹤0.01% | 6383 |
|
|
2014
Q4 | – | Sell |
-21
| Closed | -$7K | – | 8045 |
|
|
2014
Q3 | $7K | Sell |
21
-4
| -16% | -$1.17K | ﹤0.01% | 7468 |
|
|
2014
Q2 | $8K | Buy |
+25
| New | +$9.82K | ﹤0.01% | 7546 |
|
Other funds holding DMK
Bank of America's DMK Position: Q1 2024 in Review
Bank of America sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 561 shares — an estimated $392 sold.
Bank of America first reported a position in DMK in Q2 2014 and held it in 34 quarters. The position peaked at $39K in Q3 2018. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.
- Bank of America reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
- Bank of America sold 561 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $392.
- Bank of America first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2014 and held it in 34 quarters.
- Bank of America's DMK Pharmaceuticals Corporation Common Stock position peaked at $39K in Q3 2018.
- 3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.
Based on Bank of America's 13F filing for Q1 2024, filed 15 May 2024.